Manager
Howard Marks
SEC filing name: OAKTREE CAPITAL MANAGEMENT LP
All 13F filings
This quarter’s activity
2026 Q1 vs 2026 Q1 · filed 5/20/2026
| Action | Issuer | Δ Shares | Δ Port % |
|---|---|---|---|
| New | INDIVIOR PHARMACEUTICALS INC | +6,984,102 | +3.25 pp |
| New | SHARONAI HOLDINGS INC | +1,000,000 | +0.35 pp |
| New | MAYFAIR GOLD CORP | +4,500,000 | +0.21 pp |
| New | ARROWHEAD PHARMACEUTICALS INC | +11,055,000 | +0.17 pp |
| New | BLUE MOON METALS INC | +1,685,000 | +0.17 pp |
| New | ILLUMINATION ACQUISITION CORP I | +750,000 | +0.11 pp |
| Exit | Indivior Pharmaceuticals Inc | -212,875,428 | -0.11 pp |
| Add | ALVOTECH SA | +142,056 | 0.00 pp |
| Filing ID | Report period | Holdings | Value ($000) | Form type | Date filed | Name |
|---|---|---|---|---|---|---|
| 000094950926000004 | Q1 2026 | 147 | 6,557,119,230 | RESTATEMENT | 5/20/2026 | OAKTREE CAPITAL MANAGEMENT LP |
| 000094950926000003 | Q1 2026 | 142 | 6,490,931,890 | RESTATEMENT | 5/19/2026 | OAKTREE CAPITAL MANAGEMENT LP |
| 000094950926000002 | Q1 2026 | 142 | 6,284,997,721 | 13F-HR | 5/15/2026 | OAKTREE CAPITAL MANAGEMENT LP |
| 000094950926000001 | Q4 2025 | 172 | 7,027,767,837 | 13F-HR | 2/17/2026 | OAKTREE CAPITAL MANAGEMENT LP |
| 000094950925000007 | Q3 2025 | 165 | 6,490,256,632 | 13F-HR | 11/13/2025 | OAKTREE CAPITAL MANAGEMENT LP |
| 000094950925000004 | Q2 2025 | 178 | 5,814,694,465 | 13F-HR | 8/13/2025 | OAKTREE CAPITAL MANAGEMENT LP |
| 000094950925000002 | Q1 2025 | 168 | 5,169,601,827 | 13F-HR | 5/15/2025 | OAKTREE CAPITAL MANAGEMENT LP |
| 000179078725000003 | Q4 2024 | 165 | 5,635,080,962 | 13F-HR | 2/12/2025 | OAKTREE CAPITAL MANAGEMENT LP |
| 000094950924000009 | Q3 2024 | 168 | 6,238,573,040 | 13F-HR | 11/14/2024 | OAKTREE CAPITAL MANAGEMENT LP |